Glow Financial Statements From 2010 to 2025
| GLWLF Stock | USD 0.04 0.00 0.00% |
Check Glow Lifetech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Glow Lifetech's main balance sheet or income statement drivers, such as , as well as many indicators such as . Glow financial statements analysis is a perfect complement when working with Glow Lifetech Valuation or Volatility modules.
Glow |
Glow Lifetech Corp OTC Stock Current Valuation Analysis
Glow Lifetech's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Glow Lifetech Current Valuation | 4.62 M |
Most of Glow Lifetech's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Glow Lifetech Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Glow Lifetech Corp has a Current Valuation of 4.62 M. This is 99.97% lower than that of the Healthcare sector and 99.9% lower than that of the Biotechnology industry. The current valuation for all United States stocks is 99.97% higher than that of the company.
Glow Lifetech Corp Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Glow Lifetech's current stock value. Our valuation model uses many indicators to compare Glow Lifetech value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Glow Lifetech competition to find correlations between indicators driving Glow Lifetech's intrinsic value. More Info.Glow Lifetech Corp is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Glow Lifetech's earnings, one of the primary drivers of an investment's value.About Glow Lifetech Financial Statements
Glow Lifetech stakeholders use historical fundamental indicators, such as Glow Lifetech's revenue or net income, to determine how well the company is positioned to perform in the future. Although Glow Lifetech investors may analyze each financial statement separately, they are all interrelated. For example, changes in Glow Lifetech's assets and liabilities are reflected in the revenues and expenses on Glow Lifetech's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Glow Lifetech Corp. Please read more on our technical analysis and fundamental analysis pages.
Glow Lifetech Corp., a biotechnology company, focuses on producing nutraceutical and cannabinoid-based products in North America. The company was incorporated in 2018 and is based in Toronto, Canada. Glow Lifetech operates under Biotechnology classification in the United States and is traded on OTC Exchange.
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Other Information on Investing in Glow OTC Stock
Glow Lifetech financial ratios help investors to determine whether Glow OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Glow with respect to the benefits of owning Glow Lifetech security.